The Efficacy and Safety of Fecal Microbiota Transplant for Recurrent Clostridiumdifficile Infection: Current Understanding and Gap Analysis

The leading risk factor for Clostridioides (Clostridium) difficile infection (CDI) is broad-spectrum antibiotics, which lead to low microbial diversity, or dysbiosis. Current therapeutic strategies for CDI are insufficient, as they do not address the key role of the microbiome in preventing C. diffi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilcox, Mark H, McGovern, Barbara H, Hecht, Gail A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184446/
https://www.ncbi.nlm.nih.gov/pubmed/32405509
http://dx.doi.org/10.1093/ofid/ofaa114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184446/
https://www.ncbi.nlm.nih.gov/pubmed/32405509
http://dx.doi.org/10.1093/ofid/ofaa114

Ejemplares similares